We need a government that is honest, on our side and working in our best interests. Presently we do not have one.
THE ISSUE OF UNSAFE VACCINES BEING A CASE IN POINT
SOURCE: UK Reloaded
Please also visit WebWide News
Listen
Intro by Steve Cook
The Covid psyop and resultant mass-poisoning that killed and is still killing millions has alerted the citizenry to the sociopathic nature of BigPharma, its controlling financiers and crooked political fronts and stooges.
It has also alerted us to the very real probability that there is something seriously amiss with the vaccine paradigm in general.
The whole issue certainly needs a level-headed investigation by honest people determined to discover and reveal the truth whatever it maybe – as opposed to the current fashion for covering it up.
The brutal fact of the matter is that if we allow things to continue along their current path we will face a worsening scenario of mass poisoning at the hands of the parasitic criminal cartels who have hijacked our governance.
It has become painfully evident that if you permit money-grubbing, irresponsible psychopaths to operate without moral or ethical restraint or consequences for the harm they do to people, you fling wide the door for compounding misery and harm from which neither you or anybody else will be safe. Which is the situation we are now in.
The solution of course is to force our governments to serve the people rather than their puppet masters and enact laws that hold corporations and those running them accountable for their actions.
Put simply: we need a government that is honest, on our side and working in our best interests. Presently we do not have one.
I’m featuring the following article in the hope that we can get the issue of vaccines more broadly looked at by raising public awareness of how how we have been taken for a ride, used, abused and betrayed.
The Century of Forgotten Vaccine Hot Lot Disasters
How the mantra of “safe and effective” has shielded countless compromised products from scrutiny and led to the same disasters continuously repeating.
A MIDWESTERN DOCTOR
SOURCE
Producing a vaccine has many opportunities for error or contamination. Because of this, disasters continually occur from “hot vaccine lots” being unleashed onto the public. Remarkably, as the years have gone by, there has been less and less accountability for this (e.g., previously public investigations were held and people went to jail whereas now government tends to keep the hot lots on the market and deny there is a problem).
In 1967, an eminent bacteriologist wrote a book detailing many forgotten vaccine disasters under the belief (he shared with many of his anonymous colleagues) that unless his profession was honest about the dangers of vaccination, the mistakes which led to those disasters would keep on repeating.
Many of the disasters he detailed related to an excessively dangerous vaccine lot being released onto the market. Remarkably, many of the disasters he detailed mirrored what occurred in the decades that followed (e.g., this article discusses the documented DPT and anthrax hot lots which caused a tsunami of injuries in infants and veterans).
One of the largest problems with the COVID-19 vaccines were the deadly hot lots that were released onto the market. In this article, I will cover everything we know about those lots and show their remarkable parallels to the century of hot lot disasters which preceded them.
During the COVID-19 rollout, patients gradually began to realize that some of the COVID-19 vaccines were more dangerous than others. Initially this was written off as a conspiracy theory. However, as time moved forward, and more evidence emerged to support the “hot lot” hypothesis there was an increasing acceptance of this theory.
At the time, the most common theory I heard raised to account for this was that a large global experiment was being done to assess the effects of various mRNA doses (e.g., one researcher was able to show that the hot lots of each COVID vaccine brand hit the market at different times in a manner that seemed to be coordinated between the manufacturers and that Pfizer’s lots contained a simple code that correlated to their toxicity).
However, while this was possible (as you can put nothing past these people) I was more inclined to an alternative hypothesis: that it was not possible to correctly produce the mRNA vaccines at scale, so there would be a large number of production issues including many either toxic or inactive lots hitting the market.
This theory was based on both my knowledge of the specific engineering challenges the mRNA technology faced and the fact that hot lots are an enduring problem with vaccines.
Because of this, many (myself included) believe the vaccine industry concluded it wasn’t possible to completely clean up their production process while maintaining the economic viability of the vaccines, so they instead focused on getting the Federal government to exempt them from liability for their hot lots under the argument that “vaccines were essential for our national security” so a certain number of people being injured by defective vaccines was an acceptable trade-off to maintain this “vital” national resource.
Given the severity of this allegation, I will now present several incidents where ‘hot’ vaccine lots have been identified in the market.
One of the greatest challenges with producing a biological pharmaceutical is that it has to be grown in a medium (e.g., a virus within cells or a growth medium for bacteria). This introduces a few major issues.
First, if cell cultures are used, an unrecognized virus may already have infected the cells and contaminated the final product.
Second, anytime a growth medium is used, unwanted pathogens can also get in (e.g., from the air) and then grow there. This is especially problematic because the same labs that produce these products also often house harmful infectious organisms.
The entire process inevitably requires a purification stage where the undesired contaminants (e.g., unwanted bacteria, foreign DNA, or toxic components of now destroyed bacteria) are removed. Unfortunately, it is often quite difficult or costly to remove these unwanted contaminants, and the cost frequently exceeds what the manufacturers are willing to pay.
In turn, unwanted biological contaminants (euphemistically termed adventitious agents) are an enduring challenge for the pharmaceutical industry. For example, this recent 2022 review paper highlighted some of the most common “adventitious agents” (e.g., mycoplasma frequently contaminate cultures) and cited a few well-known incidents such as: